About Brontes Technologies
Brontes Technologies is a company based in Lexington (United States) founded in 2003 was acquired by 3M in October 2006. Brontes Technologies has raised $3 million across 2 funding rounds from investors including 3M, Flybridge Capital Partners and Bain Capital Ventures. Brontes Technologies operates in a competitive market with competitors including 3Shape, GelSight, iTero, Planmeca and Cadent, among others.
- Headquarter Lexington, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Brontes Technologies
Brontes Technologies has successfully raised a total of $3M across 2 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $3 million completed in October 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Brontes Technologies
Brontes Technologies has secured backing from 5 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include 3M, Flybridge Capital Partners and Bain Capital Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage tech startups are funded by Flybridge Capital Partners.
|
Locked | Locked | Locked | |
|
Venture capital fund focused on investing in multiple sectors
|
Locked | Locked | Locked | |
|
CRV is recognized as a venture capital firm investing in technology startups.
|
Locked | Locked | Locked |
Investor details for Brontes Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Brontes Technologies
Investment portfolio details for Brontes Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Brontes Technologies
Detailed financials for Brontes Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Brontes Technologies Comparisons
Peer comparison for Brontes Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Brontes Technologies
Brontes Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 3Shape, GelSight, iTero, Planmeca and Cadent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of 3D ear scanning systems
|
|
| Locked | Locked | Locked |
Optical equipment for micron-level surface geometry capture is offered.
|
|
| Locked | Locked | Locked |
Intraoral scanners and restorative devices are developed for dental imaging.
|
|
| Locked | Locked | Locked |
Specializes in dental imaging devices and software.
|
|
| Locked | Locked | Locked |
3D digital solutions are provided for orthodontic and dental industries.
|
|
| Locked | Locked | Locked |
Developer of digital-based dental ecology platform
|
Detailed competitors of Brontes Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Brontes Technologies
Complete news archive for Brontes Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Brontes Technologies
Brontes Technologies was founded in 2003 and raised its 1st funding round 1 year after it was founded.
Brontes Technologies is headquartered in Lexington, United States. It is registered at Lexington, Kentucky, United States.
Michael Roman is the current CEO of Brontes Technologies.
Brontes Technologies is a funded company, having raised a total of $3M across 2 funding rounds to date.
Brontes Technologies was founded in 2003 and is headquartered in Lexington, United States. Intraoral imaging solutions for the dental sector are developed and provided by the company. Operations focus on advanced scanning and visualization technologies used in dental diagnostics and treatment planning. Services include hardware and software integration tailored for dental professionals. The domain brontes3d.com supports these activities.
Brontes Technologies has 5 investors. Key investors include 3M, Flybridge Capital Partners, Bain Capital Ventures, CRV, and David Frankel.